Vnitr Lek 2007, 53(7-8):795-798

Subclinical thyroids disease

V. Zamrazil1,2
1 Endokrinologický ústav Praha, ředitel doc. MUDr. Vojtěch Hainer, CSc.
2 Subkatedra endokrinologie IPVZ Praha, přednosta prof. MUDr. Václav Zamrazil, DrSc.

Subclinical thyroids disease (STD) is recently defined term in clinical thyroidology, which includes mainly functional disorders. Basic diagnostic signs are: normal values of thyroid hormones (fT4, fT3) and elevated TSH level (subclinical hypothyroidism) or suppresed TSH level (subclinical hyperthyroidism). In a category of STD may be included subclinical autoimunne thyroiditis (elevated level of thyroid antigens antibodies and/or hypoechogenity in sonographic screen, increased volume of the thyroid without clinical symptoms and/or autoimminity) and microscopic lesions of papillary thyroid carcinoma. Subclinical hypothyroidism may be dangerous for tendency to development of manifest hypothyroidism and for risk of disorders of lipid profile and development of atherosclerosis and its organ complication (esp. myocardial infarction). Subclinical hyperthyroidism is a risk factor of cardiac arythmias and probably can increase a risk of cardiovascular mortality) as well for osteoporosis (esp. in peri- and post-climacteric women), and last but not least for degenerative diseases of brain (?). Indication of treatment of STD is a matter of controversies. Recomendations of experts, varied from "no therapy, monitoring only" to "treat always". Treatment of risk groups (esp. pregnant women) is probably nowadays a most rationale recommendations since results of sofisticated prospective studies will be available.

Keywords: hypothyroidism; hyperthyroidism; autoimmune thyroid disease; diagnosis; therapy

Received: March 22, 2007; Published: July 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zamrazil V. Subclinical thyroids disease. Vnitr Lek. 2007;53(7-8):795-798.
Download citation

References

  1. Biondi D, Palmieri EA, Klein M et al. Subclinical hypothyroidism. Clinical features and treatment options. Eur J Endocrinol 2005; 160: 526-534. Go to original source... Go to PubMed...
  2. Biondi B, Palmieri EA, Lombardi G et al. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002; 137: 904-914. Go to original source... Go to PubMed...
  3. Cappola AR, Fried LP, Arnold AM et al. Thyroid status, cardiovascular risk and mortality in older adults. JAMA 2006; 295: 1033-1041. Go to original source... Go to PubMed...
  4. Casey BM, Dashe JS, Wells E et al. Subclinical hypothyroidism and pregnancy outcomes. Amer Coll Obster Gynecol 2005; 291: 239-243. Go to original source... Go to PubMed...
  5. Coll NF, Surks MI, Daniels GH Subclinical thyroid disease. JAMA 2004; 291: 239-243. Go to original source... Go to PubMed...
  6. Cooper DS. Subclinical thyroid disease: concensus or condrum. Clin Endocrinol 2004; 60: 410-412. Go to original source... Go to PubMed...
  7. Drbalová K, Herdová K, Pačesová P et al. Subklinické tyreopatie. Vnitř Lék 2006; 52: 963-968. Go to PubMed...
  8. Duntas LH. Subclinical thyroid disorders: the menace of Trojen horse. J Clin Invest 2003; 36: 47-48. Go to original source... Go to PubMed...
  9. Gharib H, Tutte RM, Baskin HY et al. Concensus statement: Subclinical thyroid dysfunction. A joint statement on management from the American Association of Clinical Endcrinologists, the American Thyroid Association and The Endocrine Society. J Clin Endocrinol Metab 2005; 90: 581-588. Go to original source... Go to PubMed...
  10. Heemestra KA, Smit JWA, Eustatia Rutlen CFA et al. Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism a randomized controlled study. Clin Endocrinol 2006; 65: 737-743. Go to original source... Go to PubMed...
  11. Hollowell J, Staehling NW, Flanders WD et al. Serum TSH, T4 and thyroid antibodies in The United States population (1988 to 1994): National Health and nutrition Survey (NHA-NESIII). J Clin Endocrinol Metab 2002; 87: 484-499. Go to original source... Go to PubMed...
  12. Chueitl VB, Romaldini JH, Ward LS. Subclinical hypothyroidism increases the risk for depresion in the elderly. Arch Gerontol Geriat 2007; 44: 21-28. Go to original source... Go to PubMed...
  13. Jorde R, Waterloo K, Storhant H et al. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effects of thyroxine treeatment. J Clin Endocrinol Metab 2006; 91: 145-157. Go to original source... Go to PubMed...
  14. Kalmiju S, Mehta KM, Pols HAP et al. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol 2000; 53: 733-737. Go to original source... Go to PubMed...
  15. Mayer O jr. Je subklinická hypotyreóza rizikovým faktorem kardiovaskulárních chorob? Cor Vasa 2004; 46: 123-127.
  16. Owecki M, Michalek A, Miksch E et al. Prolonged ventricular repolarization measured by corrected QT interval (QTc) in subclinical hyperthyroidism. Horm Metabob Res 2006; 38: 38-43. Go to original source... Go to PubMed...
  17. Pinchera A Subclinical thyroid disease to treat or not to treat. Thyroid 2005; 1: 1-2.
  18. Ringel D, Mazzaferri EL. Subclinical thyroid dysfunction - can there be a consensus about consensus: editorial. J Clin Endocrinol Metab 2005; 90: 588-590. Go to original source... Go to PubMed...
  19. Rodondi N, Aujesky D,Vittingoff E et al. Subclinical hypothyroidism and the risk of coronary heart disease: A meta analysis. Amer J Med 2006; 119: 541-551. Go to original source... Go to PubMed...
  20. Sawin CT, Geller A, Wolf PA et al. Low serum thyrotropin concentration as a risk factor for atrial fibrilation in older persons. N Engl J Med 1994; 331: 1249-1252. Go to original source... Go to PubMed...
  21. Schroner Z, Lazúrová I. Diabetes mellitus a subklinické poruchy funkce štítné žlázy. DMEV 2006; 1: 7-12.
  22. Surks MI. Commentary: Subclinical thyroid dysfunction A joint statement of management from the American Association of Clinical Endocrinologists The American Thyroid Association and the Endocrine Society. J Clin Endocrinol Metab 2005; 90: 586-587. Go to original source...
  23. Surks MI, Oritz E, Daniels GH et al. Subclinical thyroid disease. JAMA 2004; 291: 228-238. Go to original source... Go to PubMed...
  24. Tauchmanová L, Nizzo V, Fonderico F et al. Reduced bone mass detected by bone utrasonography and DEXA in pre- and postmanopauzal women with endogenos subclinical hyperthyroidism. Maturites 2004; 3: 299-306. Go to original source...
  25. Turhan S, Tuhernay C, Cin MO et al. Effects of thyroxine therapy on right ventricular systolic and diastolic function in patients with subclinical hypothyroidism a study by pulsed wave tissue Doppler imaging. J Clin Endocrinol Metab 2006; 91: 3490-3493. Go to original source... Go to PubMed...
  26. Walsh JP, Brenner AP, Bulsera MK et al. Subclinical thyroid dysfunction and blood pressure a community based study. Clin Endocrinol 2006; 65: 486-491. Go to original source... Go to PubMed...
  27. Zamrazil V. Subklinické tyreopatie. Interní medicína pro praxi 2004; 6: 295-299.
  28. Zhu DF, Wang ZX, Zhang DR. fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism. Brain 2006; 129: 2923-2930. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.